Submissions from 2023
Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting., Kirsi J Rautajoki, Serafiina Jaatinen, Anja Hartewig, Aliisa M Tiihonen, Matti Annala, Iida Salonen, Masi Valkonen, Vili Simola, Elisa M Vuorinen, Anni Kivinen, Minna J Rauhala, Riikka Nurminen, Kendra K Maass, Sirpa-Liisa Lahtela, Arja Jukkola, Olli Yli-Harja, Pauli Helén, Kristian W Pajtler, Pekka Ruusuvuori, Joonas Haapasalo, Wei Zhang, Hannu Haapasalo, and Matti Nykter
Challenges and opportunities in the development of combination immunotherapy with OX40 agonists., William L Redmond
Enhancement of anti-tumor efficacy of immune checkpoint blockade by alpha-TEA., William L. Redmond, Melissa Kasiewicz, and Emmanuel T Akporiaye
Multimodal single-cell analysis of human TILs across multiple tumor types reveals heterogeneity and potential opportunities for personalized immunotherapy, Will Redmond and See all authors in comments
Advances in Cancer Immunotherapy, WL Redmond
AAPM medical physics practice guideline 13.a: HDR brachytherapy, part A., Susan L Richardson, Ivan M Buzurovic, Gil'ad N Cohen, Wesley S Culberson, Claire Dempsey, Bruce Libby, Christopher S Melhus, Robin A Miller, Daniel J Scanderbeg, and Samantha J Simiele
Journal impact factors and the future of open access publishing., Susan L Richardson and Samantha G Hedrick
Spontaneous Rupture of a Previously Asymptomatic Giant Angiomyolipoma, Reed Ritterbusch
Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry., Charles J Robbins, Aileen I Fernandez, Gang Han, Serena Wong, Malini Harigopal, Mirna Podoll, Kamaljeet Singh, Amy Ly, M Gabriela Kuba, Hannah Wen, Mary Ann Sanders, Jane Brock, Shi Wei, Oluwole Fadare, Krisztina Hanley, Julie Jorns, Olivia L Snir, Esther Yoon, Kim Rabe, T Rinda Soong, Emily S Reisenbichler, and David L Rimm
Baseline Features and Reasons for Nonparticipation in the Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) Study, a Colorectal Cancer Screening Trial., Douglas J Robertson, Jason A Dominitz, Alexander Beed, Kathy D Boardman, Barbara J Del Curto, Peter D Guarino, Thomas F Imperiale, Andrew LaCasse, Meaghan F Larson, Samir Gupta, David Lieberman, Beata Planeta, Aasma Shaukat, Shanaz Sultan, Stacy B Menees, Sameer D Saini, Philip Schoenfeld, Stephan Goebel, Erik C von Rosenvinge, Gyorgy Baffy, Ildiko Halasz, Marcos C Pedrosa, Lyn Sue Kahng, Riaz Cassim, Katarina B Greer, Margaret F Kinnard, Divya B Bhatt, Kerry B Dunbar, William V Harford, John A Mengshol, Jed E Olson, Swati G Patel, Fadi Antaki, Deborah A Fisher, Brian A Sullivan, Christopher Lenza, Devang N Prajapati, Helen Wong, Rebecca Beyth, John G Lieb, Joseph Manlolo, Fernando V Ona, Rhonda A Cole, Natalia Khalaf, Charles J Kahi, Divyanshoo R Kohli, Tarun Rai, Prateek Sharma, Jiannis Anastasiou, Curt Hagedorn, Ronald S Fernando, Christian S Jackson, M Mazen Jamal, Robert H Lee, Farrukh Merchant, Folasade P May, Joseph R Pisegna, Endashaw Omer, Dipendra Parajuli, Adnan Said, Toan D Nguyen, Claudio Ruben Tombazzi, Paul A Feldman, Leslie Jacob, Rachel N Koppelman, Kyle P Lehenbauer, Deepak S Desai, Mohammad F Madhoun, William M Tierney, Minh Q Ho, Heather J Hockman, Christopher Lopez, Emily Carter Paulson, Martin Tobi, Hugo L Pinillos, Michele Young, Nancy C Ho, Ranjan Mascarenhas, Kirrichai Promrat, Pritesh R Mutha, William M Pandak, Tilak Shah, Mitchell Schubert, Frank S Pancotto, Andrew J Gawron, Amelia E Underwood, Samuel B Ho, Priscilla Magno-Pagatzaurtundua, Doris H Toro, Charles H Beymer, Andrew M Kaz, Jill Elwing, Jeffrey A Gill, Susan F Goldsmith, Michael D Yao, Petr Protiva, Heiko Pohl, and Tassos Kyriakides
Bilateral Renal Auto-Transplantation for Retroperitoneal Sarcomas: Is It Underutilized?, Tyler P Robinson, Daniel P Milgrom, Santosh Nagaraju, William C Goggins, Kannan P Samy, and Leonidas G Koniaris
Abstract CT133: Trial in progress: a multicenter phase 1/1b dose escalation study of WTX-124 as a monotherapy and in combination with pembrolizumab in patients with selected advanced or metastatic solid tumors, I Rodriquez-Rivera, Brendan Curti, and See full list of authors in comments
Nivolumab Plus Ipilimumab in Patients With Solid Tumors With, Nitin Rohatgi, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Funda Meric-Bernstam, Evan Pisick, Olatunji B Alese, Christopher M Reynolds, Ramya Thota, Gina Vaccaro, Margaret von Mehren, Rebecca C Arend, Vi K Chiu, Herbert L Duvivier, Philip J Gold, Keely Hack, Alissa S Marr, Arthur Winer, Gina N Grantham, Dominique C Hinshaw, Abigail Gregory, Susan Halabi, and Richard L Schilsky
Intratumoral bacteria influence immunotherapy efficacy, AS Rolig, GH McGee, and Will Redmond
Antibiotic-induced yeast overgrowth impairs efficacy of aPD-1 immunotherapy, AS Rolig, GH McGee, and WL Redmond
Characterization of murine lymphocyte activation and exhaustion markers by a 14-color flow cytometry panel., Daniel Rose, Annah S Rolig, and William L. Redmond
Mitomycin Gel (UGN-101) as a Kidney-sparing Treatment for Upper Tract Urothelial Carcinoma in Patients with Imperative Indications and High-grade Disease., Kyle M Rose, Katie S Murray, Craig Labbate, Solomon Woldu, Jennifer Linehan, Joseph Jacob, Hristos Kaimakliotis, Rian Dickstein, Adam Feldman, Surena F Matin, Yair Lotan, Mitchell R Humphreys, and Wade J Sexton
Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma., Miriam I Rosenberg, Erez Greenstein, Martin Buchkovich, Ayelet Peres, Eric Santoni-Rugiu, Lei Yang, Martin Mikl, Zalman Vaksman, David L Gibbs, Dan Reshef, Amy Salovin, Meredith S Irwin, Arlene Naranjo, Igor Ulitsky, Pedro A de Alarcon, Katherine K Matthay, Victor Weigman, Gur Yaari, Jessica A Panzer, Nir Friedman, and John M Maris
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease., Peter Rossing, Florian M M Baeres, George Bakris, Heidrun Bosch-Traberg, Mette Gislum, Stephen C L Gough, Thomas Idorn, Jack Lawson, Kenneth W Mahaffey, Johannes F E Mann, Henriette Mersebach, Vlado Perkovic, Katherine Tuttle, and Richard Pratley
Safety and efficacy of D-1553 in KRAS G12C-mutated colorectal cancer: Results from a phase I/II study, D-Y Ruan, Rachel Sanborn, and See all authors in comments
Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumors., Charles M Rudin, Hardev S Pandha, Matthew Zibelman, Wallace L Akerley, Kevin J Harrington, Daphne Day, Andrew G Hill, Steven J O'Day, Timothy D Clay, Gavin M Wright, Ross R Jennens, David E Gerber, Jonathan E Rosenberg, Christy Ralph, David C Campbell, Brendan Curti, Jaime R Merchan, Yixin Ren, Emmett V Schmidt, Lisa Guttman, and Sumati Gupta
Multi-center real-world data curation and assessment of tumor growth rate and overall survival in advanced NSCLC treated with PD-(L)1 immune checkpoint inhibitor therapy, C Sako, Brendan Curti, Roshanthi Weerasignhe, and See all authors in comments
Immune Pathway Antagonists, R Sanborn
Adjuvant/Neoadjuvant/Perioperative A (Whirlwind) Tour of Recent Developments in Early-Stage NSCLC, Rachel Sanborn
Does Finding a Rare Mutation Accomplish Anything, Rachel Sanborn
Personalizing Management of Early-Stage NSCLC. Sanborn R. APP Oncology Summit; 2023 October 8; Portland, OR., Rachel Sanborn
Phase 1/2 study of the hexavalent OX40 agonist INBRX-106 alone and in combination with pembrolizumab in select solid tumors, Rachel Sanborn
The Role of SHP-2 Inhibitors Alone or in Combination, Rachel Sanborn
2166 / 8 - Analysis of ctDNA next generation sequencing (NGS) for predicting response to amivantamab and lazertinib among patients with EGFR-mutant NSCLC after progression on osimertinib and platinum-based chemotherapy (CHRYSALIS-2 Cohort A), Rachel E Sanborn and See full list of authors in comments
NSCLC with MET Amplification (METamp): Epidemiology, Disease Characteristics, Testing Procedures, and Economic and Humanistic Burden – a Targeted Literature Review, Rachel Sanborn and See all authors in comments
Phase 1/2 study of the hexavalent OX40 agonist INBRX-106 alone and in combination with pembrolizumab in select solid tumors, Rachel Sanborn and See full list of authors in comments
Breast Cancer Immunology, SE Sanborn
Immunology 101, SE Sanborn
Age-related next-generation sequencing mutational analysis in 1196 melanomas., Juan A Santamaria-Barria, Chikako Matsuba, Adam Khader, Anthony J Scholar, Mary Garland-Kledzik, Trevan D Fischer, Richard Essner, Matthew P Salomon, Joshua M V Mammen, and Melanie Goldfarb
Pafolacianine for intraoperative molecular imaging of cancer in the lung: The ELUCIDATE trial., Inderpal S Sarkaria, Linda W Martin, David C Rice, Shanda H Blackmon, Herbert B Slade, Sunil Singhal, ELUCIDATE Study Group, and Brian Louie (ELUCIDATE Study Group)
Selinexor-Based Triplet Regimens in Patients With Multiple Myeloma Previously Treated With Anti-CD38 Monoclonal Antibodies., Gary J Schiller, Brea C Lipe, Nizar J Bahlis, Sascha A Tuchman, William I Bensinger, Heather J Sutherland, Suzanne Lentzsch, Muhamed Baljevic, Darrell White, Rami Kotb, Christine I Chen, Adriana Rossi, Noa Biran, Richard LeBlanc, Sebastian Grosicki, Maurizio Martelli, Eberhard Gunsilius, Ivan Špička, Don Ambrose Stevens, Thierry Facon, Mercedes Gironella Mesa, Chris Zhang, Dane R Van Domelen, Ohad S Bentur, and Cristina Gasparetto
Preoperative Treatment of Locally Advanced Rectal Cancer., Deborah Schrag, Qian Shi, Martin R Weiser, Marc J Gollub, Leonard B Saltz, Benjamin L Musher, Joel Goldberg, Tareq Al Baghdadi, Karyn A Goodman, Robert R McWilliams, Jeffrey M Farma, Thomas J George, Hagen F Kennecke, Ardaman Shergill, Michael Montemurro, Garth D Nelson, Brian Colgrove, Vallerie Gordon, Alan P Venook, Eileen M O'Reilly, Jeffrey A Meyerhardt, Amylou C Dueck, Ethan Basch, George J Chang, and Harvey J Mamon
PROSPECT: A randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total mesorectal excision (TME) for treatment of locally advanced rectal cancer (LARC) (Alliance N1048), D Schrag, HF Kennecke, and See all authors in comments
Off-clamp Versus On-clamp Robot-assisted Partial Nephrectomy: A Propensity-matched Analysis., Gopal Sharma, Milap Shah, Puneet Ahluwalia, Prokar Dasgupta, Benjamin J Challacombe, Mahendra Bhandari, Rajesh Ahlawat, Sudhir Rawal, Nicolo M Buffi, Ananthakrishanan Sivaraman, James R Porter, Craig Rogers, Alexandre Mottrie, Ronney Abaza, Khoon Ho Rha, Daniel Moon, Thyavihally B Yuvaraja, Dipen J Parekh, Umberto Capitanio, Kris K Maes, Francesco Porpiglia, Levent Turkeri, and Gagan Gautam
The immunogenic radiation and new players in immunotherapy and targeted therapy for head and neck cancer., Shay Sharon, Narmeen Daher-Ghanem, Deema Zaid, Michael J Gough, and Nataly Kravchenko-Balasha
A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B cell lymphoma., Geoffrey Shouse, Andy Kaempf, Max J Gordon, Andrew S Artz, David Yashar, Audrey M Sigmund, Gordon Smilnak, Steven M Bair, Agrima Mian, Lindsey A Fitzgerald, Amneet Bajwa, Samantha M Jaglowski, Neil Bailey, Mazyar Shadman, Krish Patel, Deborah M Stephens, Manali Kamdar, Brian T Hill, Jordan Gauthier, Reem Karmali, Loretta J Nastoupil, Adam S Kittai, and Alexey V Danilov
A phase Ib study of interleukin-2 plus pembrolizumab for patients with advanced melanoma., Ann W Silk, Brendan Curti, Jennifer Bryan, Tracie Saunders, Weichung Shih, Michael P Kane, Phoebe Hannon, Christopher B Fountain, Jessica Felcher, Andrew Zloza, Howard L Kaufman, Janice M Mehnert, and David F McDermott
AI-based radiomic biomarkers to predict PD-(L)1 immune checkpoint inhibitor response within PD-L1 high/low/negative expression categories in stage IV NSCLC., George R. Simon, Brendan Curti, Roshanthi Weerasinghe, and See all authors in comments
Association of nutrition with psychological health and quality of life among older adults with advanced cancer, Surbhi Singhal, Alison Conlin, and See full list of authors in comments
Modulation of myeloid and T cells in vivo by Bruton's tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma., Meenal Sinha, Courtney Betts, Li Zhang, Madeline J Griffith, Isabelle Solman, Brandon Chen, Eric Liu, Whitney Tamaki, Jacob Stultz, Jaqueline Marquez, Shamilene Sivagnanam, Alexander Cheung, Denise Pener, Anne Fahlman, Erin Taber, Kimberly Lerner, Matthew Crocker, Kendra Todd, Brindha Rajagopalan, Clarisha Ware, Mark Bridge, Johnson Vo, Hannah Dragomanovich, Julie Sudduth-Klinger, Gina Vaccaro, Charles D Lopez, Margaret Tempero, Lisa M Coussens, and Lawrence Fong
Editorial. Overcoming implementation barriers in enhanced recovery using theory-based approaches., Walavan Sivakumar
Letter to the editor regarding "Vascular anomalies in patients with growth hormone-secreting pituitary adenomas: illustrative case report and systematic review of the literature"., Walavan Sivakumar and William T Couldwell
Enhanced recovery after brain tumor surgery: pilot protocol implementation in a large healthcare system., Walavan Sivakumar, Jian Guan, Jean-Philippe Langevin, Garni Barkhoudarian, Daniel F Kelly, and Neil A Martin
Treatment selection for patients with relapsed or refractory follicular lymphoma., Alan Z Skarbnik and Krish Patel
Impact of Fall Education to Nursing Staff on Oncology Patient Fall Rates, Danni Sloane
ASO Visual Abstract: Impact of Adherence to Operative Standards and Stage-Specific Guideline-Recommended Therapy in Non-metastatic Pancreatic Adenocarcinoma., Holly V Spitzer, Phillip M Kemp Bohan, Elizabeth L Carpenter, Alexandra M Adams, Shu-Ching Chang, Gary Grunkemeier, Timothy J Vreeland, Ching-Wei D Tzeng, Matthew H Katz, and Daniel W Nelson
Impact of Adherence to Operative Standards and Stage-Specific Guideline-Recommended Therapy in Nonmetastatic Pancreatic Adenocarcinoma., Holly V Spitzer, Phillip M Kemp Bohan, Elizabeth L Carpenter, Alexandra M Adams, Shu-Ching Chang, Gary Grunkemeier, Timothy J Vreeland, Ching-Wei D Tzeng, Matthew H G Katz, and Daniel W Nelson
Allogeneic Chimeric Antigen Receptor T (CAR-T) cell Immunotherapy Targeting CD70 Tumor Antigen in Patients with Metastatic Clear Cell Renal Cell Carcinoma., S Srour, Brendan Curti, and See full list of authors in comments
Breast Cancer Vaccine Landscape. Stanton S. SABCS Annual Meeting; 2023 December 5; San Antonio, TX., Sasha Stanton
Retinoid X receptor agonists enhances type I systemic and intratumoral immunity, but enhanced tumor prevention, with the HER2-IGFBP2-IGF1R plasmid vaccine in two mouse mammary tumor models, Sasha Stanton and See full list of authors in comments
Antigen Identification and Preventive Vaccine Development for Pre-Malignant Breast Lesions, SE Stanton
Clinical Trials: Patient Selection, Design, and Endpoints, SE Stanton
How does immunotherapy and your immune system work together to destroy cancer cells, SE Stanton
Primary Immunoprevention Strategies, SE Stanton
Rexinoids in Breast Cancer Prevention, SE Stanton
The Simplified Extraction of Atrial Tumor With Targeted Loop Electricity (SEATTLE) Procedure., Zachary L Steinberg, David Elison, Logan L Vincent, Donald Oxorn, and James M McCabe
Developments in Checkpoint Inhibitor Therapy for the Management of Deficient Mismatch Repair (dMMR) Rectal Cancer., Alan Su, Rodrigo Pedraza, and Hagen F Kennecke
Discordance in Total Mesorectal Excision Specimen Grading in a Prospective Phase 2 Multicenter Rectal Cancer Trial: Are We Overestimating the Quality of Our Resections?, Patricia Sylla, Mariana Berho, Dana Sands, Alison Ricardo, Antoinette Bonaccorso, Erin Moshier, Elisabeth Hain, Riva Letchinger, John Marks, Mark Whiteford, Elisabeth Mclemore, Justin Maykel, Karim Alavi, Karen Zaghiyan, Sami Chadi, Sherief F Shawki, Scott Steele, Alessio Pigazzi, Matthew Albert, Teresa DeBeche-Adams, Alexandros Polydorides, and Steven Wexner
Multicenter phase II trial of transanal total mesorectal excision for rectal cancer: preliminary results., Patricia Sylla, Dana Sands, Alison Ricardo, Antoinette Bonaccorso, Alexandros Polydorides, Mariana Berho, John Marks, Justin Maykel, Karim Alavi, Karen Zaghiyan, Mark Whiteford, Elisabeth Mclemore, Sami Chadi, Sherief F Shawki, Scott Steele, Alessio Pigazzi, Matthew Albert, Teresa DeBeche-Adams, Erin Moshier, and Steven D Wexner
Biological functions of the Olig gene family in brain cancer and therapeutic targeting., Jenny Szu, Igor F Tsigelny, Alexandre Wojcinski, and Santosh Kesari
Characterization of immunosuppressive myeloid cells in Merkel cell carcinoma: correlation with resistance to PD-1 pathway blockade., Shira Tabachnick-Cherny, Thomas Pulliam, Haroldo J Rodriguez, Xinyi Fan, Daniel S Hippe, Daniel C Jones, Ata S Moshiri, Kimberly S Smythe, Rima M Kulikauskas, Lisa Zaba, Kelly G Paulson, and Paul Nghiem
Analysis of Radiation Therapy Quality Assurance in NRG Oncology RTOG 0848., Leila T Tchelebi, Kathryn A Winter, Ross A Abrams, Howard P Safran, William F Regine, Susan McNulty, Abraham Wu, Kevin L Du, Samantha A Seaward, Shelly X Bian, Raid Aljumaily, Anand Shivnani, Jeanna L Knoble, Todd S Crocenzi, Thomas A DiPetrillo, Kevin S Roof, Christopher H Crane, and Karyn A Goodman
Final survival analysis of topotecan and paclitaxel for first-line treatment of advanced cervical cancer: An NRG oncology randomized study., Krishnansu S Tewari, Michael W Sill, Michael J Birrer, Richard T Penson, Helen Huang, David H Moore, Lois M Ramondetta, Lisa M Landrum, Ana Oaknin, Thomas J Reid, Mario M Leitao, Helen E Michael, and Bradley J Monk
Clinical Outcomes of Stereotactic Radiosurgery-Related Radiation Necrosis in Patients with Intracranial Metastasis from Melanoma., Holly M Thomson, Shannon P Fortin Ensign, Victoria S Edmonds, Akanksha Sharma, Richard J Butterfield, Steven E Schild, Jonathan B Ashman, Richard S Zimmerman, Naresh P Patel, Alan H Bryce, Sujay A Vora, Terence T Sio, and Alyx B Porter
Abstract: 927 Streamlining Cancer Immunotherapy Research with the CRI IAtlas Data Resource and Web Portal, Vésteinn Thorsson, Carolina Heimann, Andrew Lamb, David L Gibbs, Dante Bortone, Sarah Dexheimer, Steven Vensko, Yooree Chae, Ilya Shmulevich, Benjamin Vincent, and James Eddy
AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer., Sara M Tolaney, Arlene Chan, Katarina Petrakova, Suzette Delaloge, Mario Campone, Hiroji Iwata, Parvin F Peddi, Peter A Kaufman, Elisabeth De Kermadec, Qianying Liu, Patrick Cohen, Gautier Paux, Lei Wang, Nils Ternès, Eric Boitier, and Seock-Ah Im
Harnessing the T-cell response against cancer mutations, E Tran
Neoantigen T-cell receptor therapy in solid cancer, E Tran
T-cell receptor gene therapy targeting HLA-II-restricted HPV antigens, E Tran
T-cell transfer therapy targeting oncogenic neoantigens, E Tran
Lung Cancer Screening in People With HIV: A Mixed-Methods Study of Patient and Provider Perspectives., Matthew Triplette, Meagan C Brown, Madison Snidarich, Jehan Z Budak, Nicholas Giustini, Nicholas Murphy, Perrin E Romine, Bryan J Weiner, and Kristina Crothers
Outcomes of Patients Treated for Hepatoblastoma with Low Alpha-Fetoprotein and/or Small Cell Undifferentiated Histology: A Report from the Children's Hepatic Tumors International Collaboration (CHIC)., Angela D Trobaugh-Lotrario, Rudolf Maibach, Daniel C Aronson, Arun Rangaswami, Beate Häberle, Allison F O'Neill, Irene Schmid, Marc Ansari, Tomoro Hishiki, Sarangarajan Ranganathan, Rita Alaggio, Ronald R de Krijger, Yukichi Tanaka, Soo-Jin Cho, Christian Vokuhl, Rebecca Maxwell, Mark Krailo, Eiso Hiyama, Piotr Czauderna, Milton Finegold, James H Feusner, Marcio H Malogolowkin, Rebecka L Meyers, and Dolores Lopez-Terrada
Robot-assisted partial nephrectomy for complex renal tumors: Analysis of a large multi-institutional database., Burak Ucpinar, Jordan Miller Rich, Kennedy E Okhawere, Shirin Razdan, Osama Zaytoun, Laura Zuluaga, Indu Saini, Michael D Stifelman, Ronney Abaza, Daniel D Eun, Akshay Bhandari, Ashok K Hemal, James Porter, Simone Crivellero, Ahmed Mansour, Phillip M Pierorazio, and Ketan K Badani
The Impact of Prolonged Operative Time Associated with Minimally Invasive Colorectal Surgery: A Report from the Surgical Care Outcomes Assessment Program., Kenley R Unruh, Amir Bastawrous, Shalini Kanneganti, Jennifer A Kaplan, Ravi Moonka, Laila Rashidi, Arthur Sillah, and Vlad V Simianu
In Reply to Ward et al., Jayant S Vaidya, Max Bulsara, Frederik Wenz, Elena Sperk, Samuele Massarut, Michael Alvarado, Norman R Williams, Chris Brew-Graves, Marcelle Bernstein, Dennis Holmes, Lorenzo Vinante, Steffi Pigorsch, Steiner Lundgren, Valery Uhl, David Joseph, and Jeffrey S Tobias
CD103 and CD39 coexpression identifies neoantigen-specific cytotoxic T cells in colorectal cancers with low mutation burden., Jitske van den Bulk, Manon van der Ploeg, Marieke E Ijsselsteijn, Dina Ruano, Ruud van der Breggen, Rebekka Duhen, Koen C M J Peeters, Arantza Fariña-Sarasqueta, Els M E Verdegaal, Sjoerd H van der Burg, Thomas Duhen, and Noel F C C de Miranda
Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial., Floris S Verheij, Dana M Omer, Hannah Williams, Sabrina T Lin, Li-Xuan Qin, James T Buckley, Hannah M Thompson, Jonathan B Yuval, Jin K Kim, Richard F Dunne, Jorge Marcet, Peter Cataldo, Blase Polite, Daniel O Herzig, David Liska, Samuel Oommen, Charles M Friel, Charles Ternent, Andrew L Coveler, Steven Hunt, Anita Gregory, Madhulika G Varma, Brian L Bello, Joseph C Carmichael, John Krauss, Ana Gleisner, José G Guillem, Larissa Temple, Karyn A Goodman, Neil H Segal, Andrea Cercek, Rona Yaeger, Garrett M Nash, Maria Widmar, Iris H Wei, Emmanouil P Pappou, Martin R Weiser, Philip B Paty, J Joshua Smith, Abraham J Wu, Marc J Gollub, Leonard B Saltz, and Julio Garcia-Aguilar
Location, location, location: spatial analysis of ultrahigh-plex immunofluorescence panel in head and neck cancer, Q Vu, Rom Leidner, Bernard Fox, and See full list of authors in comments
Accurate Prediction of 1p/19q Co-deletion in Oligodendrogliomas Using Comprehensive Genomic Profiling, J Wagner, Carlo Bifulco, Brian Piening, and See full list of authors in comments
A cloud-based resource for genome coordinate-based exploration and large-scale analysis of chromosome aberrations and gene fusions in cancer., Janet Wang, Jeanne Zheng, Elaine E Lee, Boris Aguilar, John Phan, Kawther Abdilleh, Ronald C Taylor, William Longabaugh, Bertil Johansson, Fredrik Mertens, Felix Mitelman, David Pot, and Thomas LaFramboise
Pirtobrutinib in Covalent BTK-Inhibitor Pre-treated Mantle Cell Lymphoma., Michael L Wang, Wojciech Jurczak, Pier Luigi Zinzani, Toby A Eyre, Chan Y Cheah, Chaitra S Ujjani, Youngil Koh, Koji Izutsu, James N Gerson, Ian Flinn, Benoit Tessoulin, Alvaro J Alencar, Shuo Ma, David Lewis, Ewa Lech-Maranda, Joanna Rhodes, Krish Patel, Kami Maddocks, Nicole Lamanna, Yucai Wang, Constantine S Tam, Talha Munir, Hirokazu Nagai, Francisco Hernandez-Ilizaliturri, Anita Kumar, Timothy S Fenske, John F Seymour, Andrew D Zelenetz, Binoj Nair, Donald E Tsai, Minna Balbas, Richard A Walgren, Paolo Abada, Chunxiao Wang, Junjie Zhao, Anthony R Mato, and Nirav N Shah
Cell population growth kinetics in the presence of stochastic heterogeneity of cell phenotype., Yue Wang, Joseph X Zhou, Edoardo Pedrini, Irit R Rubin, May Khalil, Roberto Taramelli, Hong Qian, and Sui Huang
Cell Population Growth Kinetics in the Presence of Stochastic Heterogeneity of Cell Phenotype., Yue Wang, Joseph X Zhou, Edoardo Pedrini, Irit R Rubin, May Khalil, Roberto Taramelli, Hong Qian, and Sui Huang
NTRK Fusions and Concomitant Immune and Genomic Landscape Detected by DNA and RNA NGS in a Large Healthcare System, T Ward, Brian Piening, Carlo Bifulco, and See full list of authors in comments
Multi-omic characterization of RCC1 expression and its association with molecular alterations, immune phenotypes, and cancer outcomes. ASCO, Abst:3128, 6/2023., B Warnecke, Dave Hoon, and See full list of authors in comments
UCSB Pharmacology Colloquium, AD Weinberg
Using CD39/CD103 to Isolate Tumor-Reactive CD8 TIL: Bench to Bedside, AD Weinberg
T Cell Agonists. SITC Winter School Annual Meeting; 2023 January 18; Austin, TX., Andrew D Weinberg
Access to Lung Cancer Screening Among American Indians and Alaska Natives: A Qualitative Study., Allison C Welch, Sara M London, Candice Wilshire, Christopher R Gilbert, Dedra Buchwald, Gary Ferguson, Cole Allick, and Jed A Gorden
Adipocytes and ROS-Responsive hydrogels for Drug Delivery and Cancer Immunotherapy, D Wen
Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma., Jason R Westin, Frederick L Locke, Michael Dickinson, Armin Ghobadi, Mahmoud Elsawy, Tom van Meerten, David B Miklos, Matthew L Ulrickson, Miguel-Angel Perales, Umar Farooq, Luciano Wannesson, Lori Leslie, Marie José Kersten, Caron A Jacobson, John M Pagel, Gerald Wulf, Patrick Johnston, Aaron P Rapoport, Linqiu Du, Saran Vardhanabhuti, Simone Filosto, Jina Shah, Julia T Snider, Paul Cheng, Christina To, Olalekan O Oluwole, and Anna Sureda
